The particularly robust enhancement of vWF protein and mRNA expression in stromal regions of GC tumors, along with the physical proximity and functional relationship to the VEGF-VEGFR2 molecules and signaling pathway, suggest a potential pathogenic mechanism of GC and targets of future molecular therapies. Here, VEGFA is linked to gastric cancer.